Skip to main content
Marc Wein, MD, Endocrinology, Boston, MA, Massachusetts General Hospital

MarcNWeinMDPhD

Endocrinology Boston, MA

Diabetes, Lipid Metabolism

Research Fellow in Medicine, Massachusetts General Hospital

Dr. Wein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wein's full profile

Already have an account?

  • Office

    Massachusetts General Hospital
    55 Fruit St.
    Boston, MA 02114
    Phone+1 617-726-2862
    Fax+1 617-724-7441
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2011
  • Harvard Medical School
    Harvard Medical SchoolClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2024

Publications & Presentations

PubMed

Journal Articles

  • The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency  
    Marc N Wein, Michael K Mansour, Jatin M Vyas, Jayaraj Rajagopal, Mark C Fishman, Kathleen E Corey, Caroline L Sokol, Katrina A Armstrong, The Journal of Infectious Diseases

Press Mentions

  • Dr. Marc Wein: Extra Attention Should Be Paid to Fracture Risk in COPD Patients Receiving High-Dose Inhaled Corticosteroids
    Dr. Marc Wein: Extra Attention Should Be Paid to Fracture Risk in COPD Patients Receiving High-Dose Inhaled CorticosteroidsNovember 16th, 2020
  • SMURF2 Regulates Bone Homeostasis by Disrupting SMAD3 Interaction with Vitamin D Receptor in Osteoblasts
    SMURF2 Regulates Bone Homeostasis by Disrupting SMAD3 Interaction with Vitamin D Receptor in OsteoblastsFebruary 20th, 2017
  • Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
    Signaling Pathway Could Be Key to Improved Osteoporosis TreatmentOctober 19th, 2016

Professional Memberships

Hospital Affiliations